Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE 3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease … Read more

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But … Read more

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But … Read more

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that … Read more

Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC Weight Watchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial position of the company is solid and its new clinical business related to the threat … Read more

Experts hesitate on weight loss ETFs amid the obesity drug boom

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist … Read more

Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ … Read more

Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and … Read more

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and … Read more

Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 5% on Thursday morning, according to LSEG data, hitting a fresh record highs after the Danish pharmaceutical giant reported positive early trial data for a new experimental weight loss drug. The company told an investor … Read more

Novo Nordisk’s diabetes drug Ozempic slashed the risk of kidney disease progression in trial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This picture taken on October 23, 2023, shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, eastern France.  Sebastien Bozon | Afp | Getty Images Novo Nordisk‘s blockbuster drug Ozempic cut the risk of kidney disease progression and related health complications in … Read more

Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market.  Viking is just one of several companies racing to join the growing space. Some analysts say the … Read more

Viking Therapeutics emerges as a strong weight loss drug player — or takeover target

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market.  Viking is just one of several companies racing to join the growing space. Some analysts say the … Read more

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

One down one to go — what we learned from TJX’s great quarter and hope to hear from Salesforce

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. U.S. stocks were trending lower as investors awaited important inflation data and mulled over more quarterly earnings. January’s PCE price … Read more

The big health decisions Americans will need to make after starting new weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan Mcdermid | Reuters For all of the promise associated with new weight loss drugs such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound in treating … Read more

The pet drugs vets are now prescribing look a lot more like human medications

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don’t need to look much further than weight loss drugs. On the human side, Novo Nordisk and Eli Lilly struggled to meet the demand for Ozempic, Wegovy, … Read more

Healthy Returns: The newest treatment use for weight loss drugs? Liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Image of a healthy liver not ravaged by fatty liver disease. BSIP | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drugmakers aren’t just racing to develop drugs that treat obesity. They’re also competing to … Read more

Viking Therapeutics stock jumps 80% after positive weight loss drug trial results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Cr | Istock | Getty Images Shares of Viking Therapeutics soared more than 80% in premarket trading Tuesday after the company’s experimental weight loss drug showed promising initial results in a mid-stage trial.  Viking Therapeutics is one of several small obesity drugmakers hoping to enter the … Read more

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people of … Read more

What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag — typically between $1,000 to $1,500 a month — consumers are clamoring for drugs like Novo Nordisk‘s Wegovy and Eli … Read more

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month … Read more

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday on hotter-than-expected retail inflation data. The surprise uptick in the January consumer price index sent bond … Read more

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical … Read more

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments.  The dominant weight … Read more

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. Analysts at four equity research firms boosted their price targets for GE Healthcare since the maker of … Read more

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July … Read more

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Tuesday said its highly popular drug used for weight loss and diabetes showed promise as a treatment for fatty … Read more

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall … Read more

Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, … Read more

Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023.  Victoria Klesty | Reuters Novo Nordisk‘s parent company on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost … Read more

January was great for stocks — here are the top 5 performers in the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Benchmark gauges notched all-time highs as stocks charged through a busy earnings season. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more

Eli Lilly’s direct drug sales may not upend the industry alone – but others could follow suit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access.  The company’s direct-to-consumer push announced Thursday, … Read more

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three … Read more

Here are the big health sector themes to watch next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device … Read more

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond.  The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand … Read more

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market.  The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed … Read more

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the … Read more

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company’s obesity drug Zepbound. The situation seems rather clear-cut to us: It’s no reason to sell. Eli Lilly shares on Tuesday shook off afternoon losses to … Read more

Patients regain weight after stopping Eli Lilly’s Zepbound, study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took Eli Lilly‘s weight loss drug Zepbound regained around half of the weight they shed after stopping the newly approved treatment for a year, according to data released … Read more

Biden administration asserts power to seize drug patents in move to slash high prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, on Nov. 1, 2022. Kevin Lamarque | Reuters The Biden administration on Thursday asserted its authority to seize … Read more

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy. Courtesy: Eli Lilly Eli Lilly on Tuesday said its recently approved weight loss treatment Zepbound is now available at pharmacies across the U.S., serving as an alternative to rival obesity drugs … Read more

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.  The drugmaker on Friday said it will stop developing the … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study.  The drugmaker observed high rates of adverse side effects, which … Read more

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and “potentially unsafe” … Read more

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters The blockbuster diabetes drug Mounjaro is more effective for weight loss … Read more

Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market.  Analysts say upcoming data on Pfizer’s experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the … Read more

FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. George Frey | Reuters The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster … Read more

Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro … Read more

Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due … Read more

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion … Read more

Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to $71 billion by 2035, up from … Read more

Sanofi to offer insulin product for $35 to all Americans through GoodRx

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images Americans, regardless of their insurance status, can now access Sanofi‘s most widely prescribed insulin for $35 … Read more

When is it OK to violate your cost basis to buy more shares of a company?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the October Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their answers have been edited for clarity. 1. Why do rising interest rates have such a negative effect on technology stocks? (Rod) … Read more

Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

15 stocks with a history of dividend growth are expected to deliver once again this year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue in their current fiscal years. Long-term investors should look to own companies with a history of dividend growth instead … Read more

How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy.  The drugs are once-weekly injectables of a medication called semaglutide, prescribed for Type 2 diabetes and weight loss. Their skyrocketing popularity … Read more

Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer on Squawk on the Street, June 30, 2022. Virginia Sherwood | CNBC CNBC’s Jim Cramer on Monday suggested that investors keep an eye on Vertex Pharmaceuticals (VRTX), a biotechnology company developing a drug to treat acute pain that is not an opioid. “The biggest … Read more

Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage trial.  The once-daily drug helped overweight or obese participants reduce up to 10 pounds of weight on … Read more

Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.  George Frey | Reuters U.S. health care providers wrote more than nine million prescriptions for … Read more

Health care has had a tough year. Where we stand on our 5 stocks in the sector

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been a challenging period for the industry overall. Of the 11 market sectors year to date, health care … Read more

Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buy

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here are the risks to alcohol and food stocks from Ozempic-like weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The rise of new anti-obesity medications could result in less alcohol consumption, impacting Club name Constellation Brands (STZ). The risk already seems to be playing out in food stocks with exposure to snacks and junk food. However, if necessary, the Mexican beer powerhouse behind Corona, Modelo … Read more

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Tuesday sued 10 medical spas, wellness clinics and compounding … Read more

Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023.  Jaap Arriens | Nurphoto | Getty Images Heather Le Biller shed 9 pounds within the first week of taking Novo Nordisk‘s blockbuster diabetes drug Ozempic – and then … Read more

Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Ozempic drug to treat diabetes. Courtesy: Ozempic In their most recent earnings reports, Novo Nordisk and Eli Lilly proved why they are the undisputed heavyweights in the prizefight for control of the rapidly growing weight-loss medications market. Beyond staggering sales figures for Novo’s Ozempic and Wegovy … Read more

Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Weight loss drugs are being assessed for their ability to treat conditions like dementia and addiction after a landmark study showed that Wegovy helped reduce the risk of heart attacks and strokes. Bloomberg | Bloomberg | Getty Images LONDON — Scientists have begun investigating whether so-called … Read more

Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

Weight loss drugs boost sales at retail pharmacies, but they may not help profits much

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.  George Frey | Reuters Drugmakers aren’t the only ones feeling the impact of the weight … Read more

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer … Read more

Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images Blockbuster weight loss drugs are priced significantly higher in the U.S. than in other large, high-income countries, … Read more

Here’s a rapid-fire update on all 36 stocks in the Club’s portfolio, including 2 recent buys

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the Investing Club’s August Monthly Meeting, Jim Cramer provided his latest thinking on all 36 names in his Charitable Trust. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings … Read more

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the latest regulatory filings from influential Wall Street pros. These big-name investors also made moves in nine other Club stocks during a strong three-month stretch that ended the best first half … Read more

Eli Lilly gets a new price target after a big rally. Should I buy more shares?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023.  Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical … Read more

We’re optimistic about this struggling entertainment stock despite an expected weak quarter

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Back-to-back losses Still believe in Disney Eli Lilly keeps going 1. Back-to-back losses U.S. stocks on Wednesday were sinking for the … Read more

Here’s what is behind the stock market’s selloff and what we’re doing about it

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli Lilly surges Palo Alto slumps 1. Stocks sink U.S. stocks tumbled Tuesday after Moody’s downgraded the credit rating … Read more

Novavax shares jump after Covid vaccine maker posts surprise quarterly profit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Shares of Novavax jumped as much as 20% in premarket trading Tuesday after the Covid vaccine … Read more

Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline. The company now expects full-year revenue of between $33.4 billion … Read more

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. … Read more

Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or intensive lifestyle changes, according … Read more

UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images U.K. health authorities on Wednesday said they are reviewing obesity and diabetes drugs like Novo Nordisk‘s Wegovy … Read more

Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images Danish pharmaceutical giant Novo Nordisk is set to launch its hugely popular Wegovy obesity drug in Germany … Read more

Medicare is proposing to end the restriction on PET scans used to help diagnose Alzheimer’s disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jay Reinstein, who suffers from Alzheimer’s disease, sits on a bed after a PET scan at MedStar Georgetown University Hospital in Washington on June 20, 2023. Michael Robinson Chávez | The Washington Post | Getty Images Medicare plans to expand its coverage of PET scans used … Read more

Eli Lilly expects an FDA decision on the Alzheimer’s treatment with donanemab by the end of the year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly said Monday that it has applied for full approval from the U.S. Food and Drug Administration for the treatment of Alzheimer’s disease, donanemaband expects the agency … Read more

Eli Lilly to buy obesity drug maker Versanis for $1.9 billion

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly said on Friday that he would to acquire Versanis, a private company manufacturer of obesity drugsfor up to $1.93 billion to increase the pharmaceutical giant’s stake … Read more

Senator Warren says uninsured Americans are paying high costs for insulin, which Eli Lilly promised a $25 price tag.

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company’s pharmaceutical manufacturing facility is pictured at 50 ImClone Drive in Branchburg, New Jersey on March 5, 2021. Mike Segar | Reuters On average, uninsured Americans pay nearly $98 per vial Eli Lillyof generic insulin, also by company promised to cut retail price … Read more

EU expands Wegovy, Ozempic study on suicide risks to include other weight loss and diabetes drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo, boxes of the diabetes drug Ozempic sit on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images The European Union medicines regulator announced on Tuesday that it expanded the investigation in the risk of suicidal thoughts … Read more

A few patients continue to take weight-loss drugs like Wegovy after a year, but medical costs rise for all

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A selection of injection pens for the weight loss drug Wegovy are shown in this March 31, 2023 photo in Chicago, Illinois. Jim Vondruška | Reuters Prescribed only about a third of patients weight loss drugs such as Novo Nordiskinjection of hits Wegovy resumed taking a … Read more

People should stop taking Ozempic, Wegovy before surgery, a group of doctors says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this file photo, a box of the diabetes drug Ozempic sits on the counter of a pharmacy on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images People on drugs for diabetes and weight loss such as Novo NordiskOzempic and Wegovy should … Read more

As drugmakers race to develop the next big diet pill, Eli Lilly may have a head start

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly & Co.’s logo is featured in this edited photo of a pharmacy in Princeton, Illinois. seen on the insulin box. Daniel Acker | Bloomberg | Getty Images Drug manufacturers are scrambling to take advantage of the next big innovation coming in the bestseller of … Read more

Eli Lilly’s experimental obesity drug helped patients lose up to 24% of their weight, study says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli LillyThe experimental drug helped patients lose up to 24% of their weight after almost a year, the largest reduction in a place to treat obesity until today, … Read more

Novo Nordisk says high doses of an experimental obesity pill lead to 15 percent weight loss

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Novo Nordisk said it is reducing supplies of some doses of its popular anti-obesity drug in the US as it struggles to keep up with rising demand. Liselotte Sabroe | Afp | Getty Images Novo Nordiskexperimentally with high doses an anti-obesity pill it has now helped … Read more

Pfizer to end development of experimental obesity pill for elevated liver enzymes

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pavlo Gončar | Lightrocket | Getty Images Pfizer on Monday said he would stop development its experimental anti-obesity and diabetes pill, lotiglipronedue to elevated liver enzymes in once-daily patients in intermediate clinical studies. The one elevated enzymes often indicate damage to cells in the liver, but … Read more

A pharmaceutical trade group is suing the Biden administration over Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange during morning trading on April 10, 2023 in New York. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued The Biden administration is over New Medicare mandates reduce … Read more

CEOs do matter when picking stocks. 5 things we look for in a leader and examples from our portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s not unusual for a company’s stock price to soar — or sink — on news of a CEO shakeup. When Mary Dillon, revered on Wall Street for her eight-year run at Ulta Beauty (ULTA), was named to the top job at Foot Locker (FL) last … Read more

Eli Lilly to buy Dice Therapeutics for $2.4 billion to advance autoimmune treatment

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly on Tuesday said he hit a A $2.4 billion deal to acquire Dice Therapeutics in a bid to increase his treatment portfolio for immune-related diseases. Eli Lilly will pay $48 per share in cash to … Read more

Drugmakers want Supreme Court to block Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmaceutical CEOs testify before the Senate Finance Committee on “Drug Prices in America: A Prescription for Change, Part II” on February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, Chairman and CEO of AbbVie Inc; Pascal Soriot, CEO and Managing Director … Read more

Eli Lilly’s CEO says Medicare price negotiations could hurt drug development

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly CEO David Ricks said Tuesday Medicare price negotiationswhose goal is reduce costs potentially harmful for older Americans drug development. “I’m really worried about the damage this will do to new drugs and opportunities in medicine,” … Read more

We are opening a new position at one of the big three medical imaging and diagnostics companies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This company operates in an addressable market worth $84 billion, which is expected to grow to approximately $100 billion by 2024. MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Leqembi’s Alzheimer’s treatment could cost Medicare up to $5 billion a year, study estimates

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Alzheimer’s drug LEQEMBI is seen in this undated photo of a handout obtained by Reuters on January 20, 2023. Eisai | Reuters New ones Alzheimer’s diseasetreatment with antibodies Leqembi could cost Medicare up to $5 billion a year research published this week in a leading … Read more

Eli Lilly CEO vows no more insulin price hikes, while Novo Nordisk and Sanofi hedge

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly CEO Dave Ricks vowed on Wednesday not to raise the company’s prices insulin products again — the only CEO to do so before a Hearing of the Senate Committee on Health about making a life-saving diabetes drug more affordable. sen. Bernie Sandersboard chairman, asked … Read more

FDA Commissioner Praises Eli Lilly’s Alzheimer’s Treatment Results

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE FDA Commissioner Dr. Robert Califf speaks at an event celebrating hearing aids being available over the counter at Walgreens in Washington, DC on October 19, 2022. Nathan Posner | Anadolu Agency | Getty Images Commissioner for Food and Medicines dr. Robert Califf praised the results Eli … Read more

Eli Lilly’s Alzheimer’s treatment donanemab slowed disease progression in clinical trial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company’s pharmaceutical manufacturing facility is pictured at 50 ImClone Drive in Branchburg, New Jersey on March 5, 2021. Mike Segar | Reuters Treatment of Alzheimer’s disease donanemabwhich manufactures it Eli Lillysignificantly slowed the progress of the mind robbery diseaseaccording to clinical trial data … Read more

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps … Read more

Eli Lilly says the obesity drug tirzepatide has resulted in weight loss of up to 34 pounds

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist displays a box of Mounjaro, an injectable tirzepatide drug used to treat type 2 diabetes and manufactured by Lilly, at Rock Canyon Pharmacy in Provo, Utah, on May 29, 2023. George Frey | Reuters Patients who took Eli Lillyweight loss medicine tirzepatide lost up … Read more

Eli Lilly misses earnings but raises full-year guidance

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical bottles and syringes are seen with the Eli Lilly and company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli LillyFirst-quarter profit on Thursday missed expectations, … Read more

Biogen isn’t worried about competing with Eli Lilly on Alzheimer’s drugs, CEO says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A person skateboards past the headquarters of Biogen Inc. in Cambridge, Massachusetts on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen not worried about competing with Eli Lilly because both are trying to bring on alzheimer’s disease medicine to the market, Biogen’s … Read more

The CEOs of Eli Lilly, Novo Nordisk and Sanofi will testify before the Senate about lowering insulin prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This photo shows an insulin pen from Novo Nordisk on March 14, 2023 in Miami, Florida. Joe Raedle | News Getty Images | Getty Images Management of three pharmaceutical companies that control 90% of the world insulin trg will testify before the Senate Health Committee on … Read more

The Senate legislation would cap insulin at $35 a month for people with private insurance

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo, insulin pens manufactured by Novo Nordisk are shown on March 14, 2023 in Miami, Florida. Joe Raedle | Getty Images Bipartisan Senate legislation introduced Friday would cap the price of insulin at $35 a month for people with private insurance. The billprepared by … Read more

Misinformation about health is lowering life expectancy in the US, says FDA Commissioner Robert Califf

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Life expectancy in the U.S. is between three and five years lower than the average in other high-income countries — and the gap is partly due to misinformation, said Food and Drug Administration Commissioner Dr. Robert Califf. “It’s looked worse, not better, over the last few … Read more

Alzheimer’s patients retain the benefits of Leqembi even after they stop taking the drug, Eisai says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Research at Biogen Source: Biogen Alzheimer’s patients taking Leqembi maintain the benefits of treatment even after they stop taking it, new research the author Eisai shows. A Japanese drug manufacturer and its partner Biogen last week published an additional analysis of clinical trials a monoclonal antibody … Read more

Alzheimer’s patients retain the benefits of Leqembi even after they stop taking the drug, Eisai says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Research at Biogen Source: Biogen Alzheimer’s patients taking Leqembi maintain the benefits of treatment even after they stop taking it, new research the author Eisai shows. A Japanese drug manufacturer and its partner Biogen last week published an additional analysis of clinical trials a monoclonal antibody … Read more

Eli Lilly says experimental Alzheimer’s drug reduces brain plaque in early study

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical bottles and syringes are seen with the Eli Lilly and company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli LillyAn experimental Alzheimer’s drug has reduced … Read more

For investors looking for solid ground in an uncertain market, the balance sheet is king

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amid continued market volatility and renewed fears about the health of the banking sector, investors and analysts are increasingly targeting stocks of companies with excellent balance sheets. Eleven Club holdings stand out, with chipmaker Nvidia ( NVDA ) and Google parent Alphabet ( GOOGL ) at … Read more

Sanofi will cut US insulin prices in 2024, following similar cuts by Eli Lilly and Novo Nordisk

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a box of Lantus SoloStar, manufactured by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, on January 9, 2020. George Frey | Reuters Sanofi said Thursday that it plans to cut the price of its most popular insulin in the U.S. by 78% … Read more

Novo Nordisk to cut US insulin prices by up to 75% after Eli Lilly move

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE NovoLog insulin pen by Novo Nordisk Inc. are scheduled to be photographed in Brooklyn, New York, USA on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images Novo Nordisk announced plans on Tuesday to cut the price of several insulin drugs in the US … Read more

Biden’s budget would cap monthly insulin prices at $35 for people with private insurance

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A woman who had type 1 diabetes since she was a teenager shows her insulin for injection on March 2, 2023 in New York. Spencer Platt | Getty Images President Joe Biden The federal budget proposal would cap insulin prices at $35 a month for people … Read more

Eli Lilly’s Alzheimer’s treatment with solanezumab failed to slow disease progression

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly said on Wednesday it would halt development of its Alzheimer’s treatment candidate solanezumab after the antibody failed to slow the disease’s progression. The failure of solanezumab is a blow to efforts to treat Alzheimer’s disease in people who are in the very early stages … Read more

Jim Cramer’s Investment Club meeting on Monday: Fed and jobs, China reopening, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Fed and Jobs Report Stick with China Stocks Reopen Watch Eli Lilly 1. Fed and Jobs Report Stocks traded higher on … Read more

Lilly to cut insulin prices by 70%, cap prices at $35 a month for people with private insurance

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Drug manufacturer Eli Lilly & Co. said Wednesday that it would cut the prices of the most commonly prescribed insulins by 70% and cap monthly prices at $35 a month at certain retail pharmacies for people with private insurance. Lilly said it will list its Lispro … Read more

Eli Lilly Recruits Black Patients for Alzheimer’s Trial as Drugmakers Seek More Diversity in Clinical Studies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sharon Kimbrough went to the Black Women’s Expo in Atlanta to sell her memoir. Testing for Alzheimer’s disease was most on her mind, but when the nurses from Eli Lilly approached her about the company’s new trial, she decided to allow her blood to be drawn. … Read more

Biden’s proposal to cap all insulin prices at $35 a month has little chance of passing Congress

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE President Joe Biden delivers the State of the Union address to a joint session of Congress on February 7, 2023 Pool | Getty Images President Joe Biden used the bully pulpit during his State of the Union address this week to call for a blanket cap … Read more

Jim Cramer’s Investment Club Meeting Thursday: Meta, Eli Lilly, Estee Lauder

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Don’t Sell the Mint Look past Eli Lilly’s tough quarter. Opportunity to buy Estee Lauder 1. Don’t sell Meta. Shares of … Read more

Jim Cramer Investment Club Meeting Thursday: Stocks Up, Eli Lilly, Meta

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Stay Cautious Buy Eli Lilly Meta Needs More Cost Cuts 1 Stay Cautious Stocks rose on Thursday on fresh data showing … Read more

Eli Lilly is the best of both worlds—a recession-proof stock with great upside potential

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The year ahead is a crucial one for Eli Lilly ( LLY ) as the pharmaceutical giant looks to advance the drugs in its star lineup. Executives detailed reasons for optimism at a major industry meeting this week. “It’s another unprecedented year ahead for Lilly,” Chief … Read more

The Biden administration will select the top 10 drugs for Medicare price negotiations by September

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Department of Health and Human Services plans to release a list of 10 Medicare-covered drugs for price negotiations in September, the first stage in a long-awaited push to lower costs for the elderly. Speaking to reporters Wednesday, HHS officials outlined the federal government’s plan to … Read more

Jim Cramer’s Investment Club Meeting Tuesday: Microsoft, Healthcare, Emerson Electric

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Reduce Technology Exposure Watch for an Opportunity to Buy Healthcare Industry Play View 1. Reduce Technology Exposure Stocks were slightly higher … Read more

Jim Cramer’s Investment Club Meeting Monday: Industry, Tech Buy, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. We like industrialists. We believe in Amazon. LLY 1 is still bullish. We like them. Industrialists. Wall Street was lower on … Read more

Jim Cramer’s investment club meeting on Wednesday: Fed decision, Qualcomm, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Don’t Trade On Fed Decision Be Careful With QCOM Stick With Eli Lilly 1 Don’t Trade On Fed Decision Stocks gained … Read more

Jim Cramer’s Investment Club Meeting Tuesday: Inflation Cools, Stocks Lower, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Be cautious on CPI data Trim P & G Wait to buy LLY 1 Be cautious on CPI data Stocks jumped … Read more

Jim Cramer’s investment club meeting on Monday: Trimming oil, Starbucks, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Trimming HAL SBUX opportunity to lower LLY? 1. Shorting HAL We are shorting 300 shares of Halliburton (HAL) at around $38.45 … Read more

2 takeaways from our daily session: stocks await Fed decision, club earnings summary

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. The Fed’s decision is coming. Club Earnings Quick Takes 1 Fed Decision Coming Stocks fell on Wednesday ahead of the Federal … Read more

Eli Lilly’s guidance cut is related to a strong dollar, not weakening fundamentals, CEO says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly ( LLY ) CEO David Ricks on Tuesday expressed optimism about the drugmaker’s innovation plan, a sentiment he agreed with despite the club holding company’s crowded quarterly report issued earlier in the day. “The fundamentals of the business are really strong,” Ricks said in … Read more

Omicron sub-variants are resistant to key antibody treatments, putting people with weak immune systems at risk of covid

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Emerging Omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other people with weakened immune systems, making them especially vulnerable to Covid this winter, the White House warned this week. “With some of the new subvariants emerging, some of the … Read more

2 conclusions of our daily meeting: We like healthcare and basic products, club names in the news

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Healthcare and Staples Lead the Market Quick Mentions: META, DIS, SBUX 1. Healthcare and Staples Lead the Market Stocks gained on … Read more

These two strategies can help you stay diversified in any stock market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Using correlation and the barbell strategy can help make trading decisions in any market. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 Conclusions of our Daily Session: Wall Street Rebound, Small Buy, Review of Analyst Notes

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Investment Club holds its “morning meeting” every weekday at 10:20 a.m. ET. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 takeaways from our daily meeting: Stocks swing, oil down, obesity drugs fast

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Stocks Swing Sell High, Consider Buy Quick Notes: LLY, COST 1. Stocks Swing Stocks fluctuated on Thursday after starting the week … Read more

Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We don’t have Eli Lilly exclusively for the potential treatment of Alzheimer’s disease. Still, we think Biogen’s topline data is very encouraging for Lilly. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

2 takeaways from our daily session: What’s behind the rebound and the club’s stock in the news

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Market Gets Oversold Bounce Quick Club Mentions: AAPL, LLY, EL 1. Market Gets Oversold Bounce US stocks recovered from last Wednesday’s … Read more

2 takeaways from Thursday’s ‘morning meeting’: We want to buy due to market weakness

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. We have no choice but to buy quick mentions: MRVL, LLY, NVDA, META 1. We have no choice but to buy … Read more

3 Takeaways From Monday’s Meeting: Market Needs A Break Up, Some Possible Buys

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. The market needs a breakthrough to the bottom. Why Jim Invests in Two-Year Treasuries Quick Mentions: JNJ, LLY, AMZN, QCOM, DHR … Read more

Here’s how we’re positioned in the four sectors and some stocks we like in each

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer advised investors on how to build a strong portfolio amid the Federal Reserve’s fight to reduce inflation. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

3 takeaways from Wednesday’s Investing Club ‘morning meeting’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Stocks are rising – for now, we’re fans of Starbucks’ incoming CEO. Quick Notes: LLY, MRVL, BHC 1. Stocks rise – …